Circulating Neuroactive Steroid Levels in a Patient With Schizophrenia Who Showed Periodic Catatonia.

DHEAS HPA-axis catatonia cortisol neuroactive steroids stress

Journal

JCEM case reports
ISSN: 2755-1520
Titre abrégé: JCEM Case Rep
Pays: England
ID NLM: 9918609886906676

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 23 09 2022
medline: 1 11 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: epublish

Résumé

Catatonia is an abnormal psychological and behavioral state related to stress. The treatment strategy suggests the involvement of neuroactive steroids in its pathophysiology. We report a hospitalized patient with schizophrenia in whom a catatonic state occurred 7 times in 5.5 years. Blood levels of steroid hormones and adrenocorticotropic hormone (ACTH) were measured during the catatonic state and in the intervals between catatonic states (non-catatonic states). Cortisol and dehydroepiandrosterone sulfate (DHEAS) were significantly higher during catatonia than in the non-catatonic state. Cortisol significantly correlated with the ACTH level, whereas blood DHEAS and progesterone correlated only during the non-catatonic state. In addition, the cortisol to DHEAS ratios did not differ between catatonic and non-catatonic states. Although the correlating elevations of ACTH and cortisol implied activation of the hypothalamic-pituitary-adrenal axis (HPA-axis) in the catatonic state, DHEAS levels did not seem to increase in a manner dependent on the HPA-axis or the production of progesterone. The results suggest that the catatonic state was a neuroendocrinological state of HPA-axis activation with comparable increases in DHEAS levels.

Identifiants

pubmed: 37908260
doi: 10.1210/jcemcr/luad009
pii: luad009
pmc: PMC10578402
doi:

Types de publication

Case Reports

Langues

eng

Pagination

luad009

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Front Psychiatry. 2014 Dec 09;5:181
pubmed: 25538636
Gynecol Endocrinol. 2006 Nov;22(11):627-35
pubmed: 17145649
BMC Psychol. 2022 Jul 15;10(1):173
pubmed: 35841077
Maturitas. 2003 Jul 25;45(3):231-5
pubmed: 12818469
Psychoneuroendocrinology. 2018 Mar;89:92-102
pubmed: 29334627
East Asian Arch Psychiatry. 2017 Jun;27(2):79-84
pubmed: 28652501
J Steroid Biochem Mol Biol. 2015 Jan;145:273-80
pubmed: 24892797
Psychoneuroendocrinology. 2021 Jan;123:104916
pubmed: 33169678
Neuroscience. 2011 Sep 15;191:91-100
pubmed: 21549182
Biol Psychol. 2012 May;90(2):143-9
pubmed: 22445967

Auteurs

Katsumasa Muneoka (K)

Gakuji-Kai Kimura Hospital, Chiba 260-0004, Japan.
Department of Anatomy I, Showa University School of Medicine, Tokyo 142-8555, Japan.

Yukihiko Shirayama (Y)

Department of Psychiatry, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan.

Hiroyuki Watanabe (H)

Gakuji-Kai Kimura Hospital, Chiba 260-0004, Japan.

Hiroshi Kimura (H)

Gakuji-Kai Kimura Hospital, Chiba 260-0004, Japan.

Classifications MeSH